{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:24:56Z","timestamp":1775244296077,"version":"3.50.1"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"10","funder":[{"DOI":"10.13039\/100000071","name":"NICHD","doi-asserted-by":"publisher","award":["1R01HD070888-01A1"],"award-info":[{"award-number":["1R01HD070888-01A1"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004870","name":"Research Foundation of NY","doi-asserted-by":"publisher","award":["1115107"],"award-info":[{"award-number":["1115107"]}],"id":[{"id":"10.13039\/100004870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"C-STEP and NIDA","doi-asserted-by":"publisher","award":["DA046794"],"award-info":[{"award-number":["DA046794"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Attention Deficit Hyperactivity Disorder (ADHD) can be comorbid with\ndepression, often leading to the prescription of both methylphenidate (MP) and selective serotonin\nreuptake inhibitor (SSRI) antidepressants, such as fluoxetine (FLX). Moreover, these drugs are often\nmisused as cognitive enhancers. This study examined the effects of chronic oral co-administration of\nMP and FLX on depressive- and anxiety-like behaviors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Adolescent rats received daily either water (control), MP, FLX, or the combination of MP\nplus FLX in their drinking water over the course of 4 weeks.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Data analysis shows a decrease in food consumption and body weight for rats exposed to\nFLX or the combination of MP and FLX. Sucrose consumption was significantly greater in FLX or\nMP+FLX groups compared to controls. FLX-treated rats showed no effect in the elevated plus maze\n(EPM; open arm time) and forced swim test (FST; latency to immobility). However, rats treated with\nthe combination (MP+FLX) showed significant anxiolytic-like and anti-depressive-like behaviors (as\nmeasured by EPM and FST), as well as significant increases in overall activity (distance traveled in\nopen field test). Finally, the combined MP+FLX treatment induced a decrease in anxiety and depressive-\nlike behaviors significantly greater than the response from either of these drugs alone.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These behavioral results characterize the long-term effects of these drugs (orally administered)\nthat are widely co-administered and co-misused and provide important insight into the potential\nneurobiological and neurochemical effects. Future research will determine the potential risks of\nthe long-term use of MP and FLX together.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201024666221028092342","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T19:18:15Z","timestamp":1666984695000},"page":"1307-1314","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Combined Chronic Oral Methylphenidate and Fluoxetine Treatment\nDuring Adolescence: Effects on Behavior"],"prefix":"10.2174","volume":"24","author":[{"given":"Panayotis K.","family":"Thanos","sequence":"first","affiliation":[{"name":"Behavioral Neuropharmacology and Neuroimaging Laboratory (BNNL), Clinical Research Institute on Addictions,\nDepartment of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo,\nBuffalo, NY 14051, USA"},{"name":"Department of Psychology, University at Buffalo, Buffalo, NY, 14203, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Blum","sequence":"first","affiliation":[{"name":"College of\nOsteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Behavioral Neuropharmacology and Neuroimaging Laboratory (BNNL), Clinical Research Institute on Addictions,\nDepartment of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo,\nBuffalo, NY 14051, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Senior","sequence":"additional","affiliation":[{"name":"Behavioral Neuropharmacology and Neuroimaging Laboratory (BNNL), Clinical Research Institute on Addictions,\nDepartment of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo,\nBuffalo, NY 14051, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Watts","sequence":"additional","affiliation":[{"name":"Behavioral Neuropharmacology and Neuroimaging Laboratory (BNNL), Clinical Research Institute on Addictions,\nDepartment of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo,\nBuffalo, NY 14051, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Connor","sequence":"additional","affiliation":[{"name":"Behavioral Neuropharmacology and Neuroimaging Laboratory (BNNL), Clinical Research Institute on Addictions,\nDepartment of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo,\nBuffalo, NY 14051, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikki","family":"Hammond","sequence":"additional","affiliation":[{"name":"Behavioral Neuropharmacology and Neuroimaging Laboratory (BNNL), Clinical Research Institute on Addictions,\nDepartment of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo,\nBuffalo, NY 14051, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hadjiargyrou","sequence":"additional","affiliation":[{"name":"Department of\nLife Sciences, New York Institute of Technology, Old Westbury, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Stony Brook\nUniversity, Stony Brook, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Steiner","sequence":"additional","affiliation":[{"name":"Stanson Toshok Center for Brain Function and Repair, Rosalind Franklin University\nof Medicine and Science, North Chicago, IL 60064, USA"},{"name":"Discipline of Cellular and Molecular Pharmacology, The\nChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","volume":"53","author":"Visser S.N.","year":"2014","unstructured":"Visser S.N.; Danielson M.L.; Bitsko R.H.; Holbrook J.R.; Kogan M.D.; Ghandour R.M.; Perou R.; Blumberg S.J.; Trends in the par-ent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry 2014,53(1),34-46","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/psychiatry.IndianJPsychiatry_333_17","volume":"61","author":"Catherine T.G.","year":"2019","unstructured":"Catherine T.G.; Robert N.G.; Mala K.K.; Kanniammal C.; Arullapan J.; Assessment of prevalence of attention deficit hyperactivity dis-order among schoolchildren in selected schools. Indian J Psychiatry 2019,61(3),232-237","journal-title":"Indian J Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1590\/S1980-5764-2016DN1002009","volume":"10","author":"Batistela S.","year":"2016","unstructured":"Batistela S.; Bueno O.F.A.; Vaz L.J.; Galdur\u00f3z J.C.F.; Methylphenidate as a cognitive enhancer in healthy young people. Dement Neuropsychol 2016,10(2),134-142","journal-title":"Dement Neuropsychol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2174\/1874473710902020157","volume":"2","author":"Bogle K.","year":"2009","unstructured":"Bogle K.; Smith B.; Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr Drug Abuse Rev 2009,2(2),157-176","journal-title":"Curr Drug Abuse Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1592\/phco.26.10.1501","volume":"26","author":"Teter C.J.","year":"2006","unstructured":"Teter C.J.; McCabe S.E.; LaGrange K.; Cranford J.A.; Boyd C.J.; Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006,26(10),1501-1510","journal-title":"Pharmacotherapy"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.4088\/JCP.14m09291","volume":"77","author":"Chen L.Y.","year":"2016","unstructured":"Chen L.Y.; Crum R.M.; Strain E.C.; Alexander G.C.; Kaufmann C.; Mojtabai R.; Prescriptions, nonmedical use, and emergency de-partment visits involving prescription stimulants. J Clin Psychiatry 2016,77(3),e297-e304","journal-title":"J Clin Psychiatry"},{"key":"ref=7","first-page":"356","volume":"27","author":"Xia W.","year":"2015","unstructured":"Xia W.; Shen L.; Zhang J.; Comorbid anxiety and depression in school-aged children with attention deficit hyperactivity disorder (ADHD) and selfreported symptoms of ADHD, anxiety, and depression among parents of school-aged children with and without ADHD. Shanghai Arch Psychiatry 2015,27(6),356-367","journal-title":"Shanghai Arch Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2010.127","volume":"67","author":"Chronis-Tuscano A.","year":"2010","unstructured":"Chronis-Tuscano A.; Molina B.S.G.; Pelham W.E.; Applegate B.; Dahlke A.; Overmyer M.; Lahey B.B.; Very early predictors of ado-lescent depression and suicide attempts in children with attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 2010,67(10),1044-1051","journal-title":"Arch Gen Psychiatry"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1186\/s12888-016-0716-x","volume":"16","author":"Hartz I.","year":"2016","unstructured":"Hartz I.; Skurtveit S.; Steffenak A.K.; Karlstad \u00d8.; Handal M.; Psychotropic drug use among 0-17 year olds during 2004-2014: a na-tionwide prescription database study. BMC Psychiatry 2016,16,1471-244X","journal-title":"BMC Psychiatry"},{"key":"ref=10","first-page":"207","author":"Van Waes V.","year":"2015","unstructured":"Van Waes V.; Steiner H.; Fluoxetine and other SSRI antidepressants potentiate addiction-related gene regulation by psychostimulant med-ications. Fluoxetine: Pharmacology, Mechanisms of Action and Potential Side Effects 2015,207-225","journal-title":"Fluoxetine: Pharmacology, Mechanisms of Action and Potential Side Effects"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuropharm.2014.08.024","volume":"89","author":"Van Waes V.","year":"2015","unstructured":"Van Waes V.; Ehrlich S.; Beverley J.A.; Steiner H.; Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: Potential role for 5-HT1B receptor. Neuropharmacology 2015,89,77-86","journal-title":"Neuropharmacology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1007\/s12035-021-02466-y","volume":"58","author":"Moon C.","year":"2021","unstructured":"Moon C.; Marion M.; Thanos P.K.; Steiner H.; Fluoxetine potentiates oral methylphenidate-induced gene regulation in the rat striatum. Mol Neurobiol 2021,58(10),4856-4870","journal-title":"Mol Neurobiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pbb.2015.01.005","volume":"131","author":"Thanos P.K.","year":"2015","unstructured":"Thanos P.K.; Robison L.S.; Steier J.; Hwang Y.F.; Cooper T.; Swanson J.M.; Komatsu D.E.; Hadjiargyrou M.; Volkow N.D.; A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior. Pharmacol Biochem Behav 2015,131,143-153","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2018.07.001","volume":"172","author":"Martin C.","year":"2018","unstructured":"Martin C.; Fricke D.; Vijayashanthar A.; Lowinger C.; Koutsomitis D.; Popoola D.; Hadjiargyrou M.; Komatsu D.E.; Thanos P.K.; Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period. Pharmacol Biochem Behav 2018,172,22-32","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"AF01","DOI":"10.7860\/JCDR\/2016\/16482.7376","volume":"10","author":"Aggarwal A.","year":"2016","unstructured":"Aggarwal A.; Jethani S.L.; Rohatgi R.K.; Kalra J.; Selective serotonin re-uptake inhibitors (SSRIs) induced weight changes: a dose and duration dependent study on albino rats. J Clin Diagn Res 2016,10(3),AF01-3","journal-title":"J Clin Diagn Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnbeh.2017.00053","volume":"11","author":"Robison L.S.","year":"2017","unstructured":"Robison L.S.; Michaelos M.; Gandhi J.; Fricke D.; Miao E.; Lam C.Y.; Mauceri A.; Vitale M.; Lee J.; Paeng S.; Komatsu D.E.; Hadjiargyrou M.; Thanos P.K.; Sex differences in the physiological and behavioral effects of chronic oral methylphenidate treatment in rats. Front Behav Neurosci 2017,11(53),53","journal-title":"Front Behav Neurosci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"Walf A.A.","year":"2007","unstructured":"Walf A.A.; Frye C.A.; The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007,2(2),322-328","journal-title":"Nat Protoc"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbr.2018.08.014","volume":"356","author":"Carias E.","year":"2019","unstructured":"Carias E.; Fricke D.; Vijayashanthar A.; Smith L.; Somanesan R.; Martin C.; Kalinowski L.; Popoola D.; Hadjiargyrou M.; Komatsu D.E.; Thanos P.K.; Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and phys-iological effects. Behav Brain Res 2019,356,189-196","journal-title":"Behav Brain Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1687-9856-2012-30","volume":"2012","author":"Poulton A.","year":"2012","unstructured":"Poulton A.; Briody J.; McCorquodale T.; Melzer E.; Herrmann M.; Baur L.A.; Duque G.; Weight loss on stimulant medication: how does it affect body composition and bone metabolism? \u2013 A prospective longitudinal study. Int J Pediatr Endocrinol 2012,2012(1),30-30","journal-title":"Int J Pediatr Endocrinol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1542\/peds.98.4.763","volume":"98","author":"Schertz M.","year":"1996","unstructured":"Schertz M.; Adesman A.R.; Alfieri N.E.; Bienkowski R.S.; Predictors of weight loss in children with attention deficit hyperactivity dis-order treated with stimulant medication. Pediatrics 1996,98(4),763-769","journal-title":"Pediatrics"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.resp.2013.02.020","volume":"186","author":"Hodges M.R.","year":"2013","unstructured":"Hodges M.R.; Echert A.E.; Puissant M.M.; Mouradian G.C.; Jr Fluoxetine augments ventilatory CO2 sensitivity in Brown Norway but not Sprague dawley rats. Respir Physiol Neurobiol 2013,186(2),221-228","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2014-3421","volume":"100","author":"Domecq J.P.","year":"2015","unstructured":"Domecq J.P.; Prutsky G.; Leppin A.; Sonbol M.B.; Altayar O.; Undavalli C.; Wang Z.; Elraiyah T.; Brito J.P.; Mauck K.F.; Lababidi M.H.; Prokop L.J.; Asi N.; Wei J.; Fidahussein S.; Montori V.M.; Murad M.H.; Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab 2015,100(2),363-370","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","volume":"71","author":"Serretti A.","year":"2010","unstructured":"Serretti A.; Mandelli L.; Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010,71(10),1259-1272","journal-title":"J Clin Psychiatry"},{"key":"ref=24","first-page":"51","volume":"295","author":"Gerasimov M.R.","year":"2000","unstructured":"Gerasimov M.R.; Franceschi M.; Volkow N.D.; Gifford A.; Gatley S.J.; Marsteller D.; Molina P.E.; Dewey S.L.; Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. J Pharmacol Exp Ther 2000,295(1),51-57","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"10347","DOI":"10.1523\/JNEUROSCI.1470-11.2011","volume":"31","author":"Warren B.L.","year":"2011","unstructured":"Warren B.L.; I\u00f1iguez S.D.; Alcantara L.F.; Wright K.N.; Parise E.M.; Weakley S.K.; Bola\u00f1os-Guzm\u00e1n C.A.; Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood. J Neurosci 2011,31(28),10347-10358","journal-title":"J Neurosci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-010-1844-5","volume":"210","author":"Sperling R.E.","year":"2010","unstructured":"Sperling R.E.; Gomes S.M.; Sypek E.I.; Carey A.N.; McLaughlin J.P.; Endogenous kappa-opioid mediation of stress-induced potentia-tion of ethanol-conditioned place preference and self-administration. Psychopharmacology 2010,210(2),199-209","journal-title":"Psychopharmacology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11011-020-00547-w","volume":"35","author":"Cola\u00e7o C.S.","year":"2020","unstructured":"Cola\u00e7o C.S.; Alves S.S.; Nolli L.M.; Pinheiro W.O.; de Oliveira D.G.R.; Santos B.W.L.; Pic-Taylor A.; Mortari M.R.; Caldas E.D.; Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats. Metab Brain Dis 2020,35(5),739-751","journal-title":"Metab Brain Dis"},{"key":"ref=28","first-page":"115","volume":"58","author":"Zienowicz M.","year":"2006","unstructured":"Zienowicz M.; Wis\u0142owska-Stanek A.; Lehner M.; Taracha E.; Maciejak P.; Sobolewska A.; Szyndler J.; Turzy\u0144ska D.; Walkowiak J.; P\u0142a\u017anik A.; Fluoxetine-induced anxiety and nervousness. Pharmacol Rep 2006,58(1),115-119","journal-title":"Pharmacol Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.npp.1301445","volume":"33","author":"Borycz J.","year":"2008","unstructured":"Borycz J.; Zapata A.; Quiroz C.; Volkow N.D.; Ferr\u00e9 S.; 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. Neuropsychopharmacology 2008,33(3),619-626","journal-title":"Neuropsychopharmacology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1460-9568.2010.07294.x","volume":"32","author":"Van Waes V.","year":"2010","unstructured":"Van Waes V.; Beverley J.; Marinelli M.; Steiner H.; Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum. Eur J Neurosci 2010,32(3),435-447","journal-title":"Eur J Neurosci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.baga.2014.10.001","volume":"4","author":"Beverley J.A.","year":"2014","unstructured":"Beverley J.A.; Piekarski C.; Van Waes V.; Steiner H.; Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates. Basal Ganglia 2014,4(3-4),109-116","journal-title":"Basal Ganglia"},{"key":"ref=32","first-page":"189","volume":"51","author":"Kercmar J.","year":"2014","unstructured":"Kercmar J.; Majdic G.; Sex-specific behavioral effects of fluoxetine treatment in animal models of depression and anxiety. Slov Vet Res 2014,51,189-200","journal-title":"Slov Vet Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1523\/JNEUROSCI.1600-08.2008","volume":"28","author":"Kobayashi S.","year":"2008","unstructured":"Kobayashi S.; Schultz W.; Influence of reward delays on responses of dopamine neurons. J Neurosci 2008,28(31),7837-7846","journal-title":"J Neurosci"},{"key":"ref=34","first-page":"98","volume":"13","author":"Cheung A.","year":"2004","unstructured":"Cheung A.; Emslie G.J.; Maynes T.L.; Efficacy and safety of antidepressants in youth depression. Canadian Child Adol Psychiatry Rev 2004,13(4),98-104","journal-title":"Canadian Child Adol Psychiatry Rev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/npp.2009.47","volume":"34","author":"Oh J-e.","year":"2009","unstructured":"Oh J-e.; Zupan B.; Gross S.; Toth M.; Paradoxical anxiogenic response of juvenile mice to fluoxetine. Neuropsychopharmacology 2009,34(10),2197-2207","journal-title":"Neuropsychopharmacology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1126\/science.1101678","volume":"306","author":"Ansorge M.S.","year":"2004","unstructured":"Ansorge M.S.; Zhou M.; Lira A.; Hen R.; Gingrich J.A.; Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004,306(5697),879-881","journal-title":"Science"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1007\/s00213-015-4003-1","volume":"232","author":"Amodeo L.R.","year":"2015","unstructured":"Amodeo L.R.; Greenfield V.Y.; Humphrey D.E.; Varela V.; Pipkin J.A.; Eaton S.E.; Johnson J.D.; Plant C.P.; Harmony Z.R.; Wang L.; Crawford C.A.; Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats. Psychopharmacology 2015,232(19),3515-3528","journal-title":"Psychopharmacology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1523\/JNEUROSCI.5725-12.2014","volume":"34","author":"I\u00f1iguez S.D.","year":"2014","unstructured":"I\u00f1iguez S.D.; Alcantara L.F.; Warren B.L.; Riggs L.M.; Parise E.M.; Vialou V.; Wright K.N.; Dayrit G.; Nieto S.J.; Wilkinson M.B.; Lobo M.K.; Neve R.L.; Nestler E.J.; Bola\u00f1os-Guzm\u00e1n C.A.; Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood. J Neurosci 2014,34(3),1007-1021","journal-title":"J Neurosci"},{"key":"ref=39","first-page":"98","author":"Freeman E.D.","year":"2015","unstructured":"Freeman E.D.;  An Analysis of the Interaction of Methylphenidate and Nicotine in Adolescent Rats: Effects on BDNF 2015,98","journal-title":"An Analysis of the Interaction of Methylphenidate and Nicotine in Adolescent Rats: Effects on BDNF"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/dev.21902","volume":"62","author":"Kalinowski L.","year":"2020","unstructured":"Kalinowski L.; Connor C.; Somanesan R.; Carias E.; Richer K.; Smith L.; Martin C.; Mackintosh M.; Popoola D.; Hadjiargyrou M.; Komatsu D.E.; Thanos P.K.; Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects. Dev Psychobiol 2020,62(2),170-180","journal-title":"Dev Psychobiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/syn.21569","volume":"66","author":"Brookshire B.R.","year":"2012","unstructured":"Brookshire B.R.; Jones S.R.; Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine. Synapse 2012,66(9),844-847","journal-title":"Synapse"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.biopsych.2003.08.020","volume":"54","author":"Carlezon W.A.","year":"2003","unstructured":"Carlezon W.A.; Mague S.D.; Andersen S.L.; Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 2003,54(12),1330-1337","journal-title":"Biol Psychiatry"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/0269881118822141","volume":"33","author":"Millard S.J.","year":"2019","unstructured":"Millard S.J.; Lum J.S.; Fernandez F.; Weston-Green K.; Newell K.A.; Perinatal exposure to fluoxetine increases anxiety- and depres-sive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison be-tween Sprague-Dawley rats and the Wistar-Kyoto rat model of depression. J Psychopharmacol 2019,33(2),230-243","journal-title":"J Psychopharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1744-9081-7-41","volume":"7","author":"Vorhees C.V.","year":"2011","unstructured":"Vorhees C.V.; Morford L.R.; Graham D.L.; Skelton M.R.; Williams M.T.; Effects of periadolescent fluoxetine and paroxetine on ele-vated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug. Behav Brain Funct 2011,7(1),41","journal-title":"Behav Brain Funct"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/dev.21385","volume":"58","author":"Boulle F.","year":"2016","unstructured":"Boulle F.; Pawluski J.L.; Homberg J.R.; Machiels B.; Kroeze Y.; Kumar N.; Steinbusch H.W.; Kenis G.; Van den Hove D.L.; Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male off-spring. Dev Psychobiol 2016,58(4),427-438","journal-title":"Dev Psychobiol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2013.09.010","volume":"114","author":"McNamara R.K.","year":"2013","unstructured":"McNamara R.K.; Able J.A.; Liu Y.; Jandacek R.; Rider T.; Tso P.; Lipton J.W.; Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats. Pharmacol Biochem Behav 2013,114,1-8","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201024666221028092342","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210435\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201024666221028092342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T07:06:25Z","timestamp":1690182385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210435\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201024666221028092342","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}